Cathryn Hope
Cathryn Hope is a global sales/marketing executive with twenty years of commercial experience in the biologics and pharmaceutical industries. She was most recently Head of the Global Immunology and Hyperimune franchises for Talecris Biotherapeutics (previously Bayer Biological Products) with sales of $700 million and prior to that was in the leadership team that established CSL Behring (previously ZLB Behring/Bioplasma) in the USA in 2000.
An Affiliate Expert of TCG and independent consultant, Cathryn has specialty therapeutic experience with immunology/vaccines, thrombosis and hemostasis, neurology and oncology products. Cathryn has extensive launch experience in US, Canada, Europe, Asia and Australia that ranges from pre-launch marketing of botulinum toxin in France to launching multiple new plasma product brands and a new company (ZLB Bioplasma) in the USA. Her commercial experience encompasses global business strategy development and implementation, comprehensive brand and launch marketing, new product development, opinion leader development and corporate and web communications.
Cathryn has a B.S. in Immunology/Biochemistry from the University of Melbourne and a Masters of Marketing from the Melbourne Business School/Charles Sturt University in Australia.
